Future studies aiming to study (NMD) system efficiently on CACP patients’ samples could shed lights on the effect of these PTC mutations of PRG4 gene in CACP patients’ phenotype. This evidence concerns the gene PRG4 and camptodactyly-arthropathy-coxa vara-pericarditis syndrome.